According to GEPIA database, PDE4DIP was down‐regulated in AML compared with normal samples (p < .01), and high expression of PDE4DIP was associated with poor AML prognosis (HR = 2.3, logrank p = .0027, Figure S1). The gene discussed is PDE4DIP; the disease is acute myeloid leukemia.